Peak sales per new pharmaceutical asset 2010-2019

This statistic shows the average peak sales amount per new pharmaceutical pipeline asset from 2010 to 2019, in million U.S. dollars. In the original study cohort, the average peak sales per asset dropped from 816 million U.S. dollars in 2010 to 376 million U.S. dollars in 2019.

Peak sales for each new pharmaceutical asset from 2010 to 2019, by study cohort

Exclusive Premium statistic

You need a Single Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Single Account

$39 $59 per month *
in the first 12 months
33% Discount until June 30th
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$468 / Year
$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in
Sources

Release date

2019

Region

Worldwide

Survey time period

2010 to 2019

Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Single Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract; Prices do not include sales tax.

Statistics on "Pharmaceutical industry in the United Kingdom (UK)"

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.